Optum Rx
Pharmacy Insights Podcast
Listen to our resident experts discuss critical industry challenges and the solutions you need to control rising drug costs.
Hosted by Scott Draeger
Tackling industry challenges, one episode at a time
The pharmaceutical industry is constantly changing and it’s hard to stay on top of it. The Pharmacy Insights Podcast is here to help you stay current, diving deep into the complex topics that are challenging your pharmacy benefit plan and give you solutions to control your rising costs.
Join our host, Optum Rx Senior Vice President of Clinical Consulting, Scott Draeger, as he interviews our residential experts on pressing topics and the industry challenges every plan sponsor is facing.
March 29, 2023
The Seismic Shift in Weight Loss Medicines
Resident experts: Optum Rx Associate Chief Medical Officer, Dr. Ana Bhatnagar and Optum Rx Vice President of Clinical Solutions, Dr. Travis Baughn
One of the most pronounced changes in the pharmacy landscape over the past year has been the rapid emergence of a new class of medications for weight loss known as GLP-1 agonists. Hear what broader use of these promising yet expensive medications for weight loss means for both patients and plan sponsors.
November 21, 2022
The risky business of alternative funding
Resident expert: Optum Rx Chief Pharmacy Officer, Michael Einodshofer
A growing industry of small alternate funding companies are promising to cover specialty medical funding on behalf of small and mid-sized companies by using money from charitable foundations. What are the real risks from this business model for plan sponsors and their members?
October 26, 2022
What you can and can’t expect from biosimilars
Resident expert: Optum Rx Senior Vice President of Clinical and Formulary Services, Savitha Vivian, PharmD
An alternative to Humira is coming. But is this a revolution, or something less?
September 14, 2022
What's happening in specialty pharmacy?
Resident expert: Optum Rx Chief Pharmacy Officer, Michael Einodshofer
Specialty medications continue to be the single largest driver of drug spending. What specifics steps can be taken to mitigate rising specialty spend? What do new advances such as gene therapies mean for future specialty costs?
Listen on your favorite podcast app
Subscribe to Pharmacy Insights Podcast
Get future episodes in your inbox.